Flyway Health is building what it calls the first autonomous insights engine for the pharmaceutical industry. The platform deploys a coordinated team of AI agents that pore over claims data, formulary information, and other commercial datasets to diagnose what is blocking a drug brand’s growth. Within one week, the system delivers clear, actionable recommendations to brand leads, eliminating the need to sift through multiple dashboards and static reports. By producing targeted growth models and next-step guidance, Flyway aims to become an essential decision-support layer for pharma commercial teams. The company emphasizes speed and customer empathy, positioning itself as a partner that can answer pressing commercial questions ASAP. Flyway has secured $3 million in seed financing to accelerate product development and customer acquisition efforts. No revenue or user metrics were disclosed in the announcement.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Nov 2025